Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cancer cells. They bind to specific proteins on the surface of cancer cells. Examples include Rituximab, used for certain types of lymphomas and leukemias, and Trastuzumab, used for HER2-positive breast cancer.
